LETTERS FOR ISSUE ON
|
|
|
- Gavin Ellis
- 5 years ago
- Views:
Transcription
1 S FOR ISSUE ON NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. INTAS PHARMACEUTICAL 6613 APPROVAL /CLARIFICATION 2. DIVINNE SBR ITERNATIONAL PVT CLARIFICATION IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. MEHTA PHARMACEUTICAL CLARIFICATION INDUSTRIES 2. AQUATIC REMEDIES PVT CLARIFICATION 3. NOVARTIS HEATLHCARE PVT CLARIFICATION 4. SKIES 20116, CLARIFICATION 5. RIOTH HEALTHCARE PVT CLARIFICATION 6. MICRO LABS CLARIFICATION 7. PIRAMAL ENTERPRISES CLARIFICATION 8. BRENNTAG INGREDEINTS CLARIFICATION
2 9. UNIMAX CHEMICALS CLARIFICATION 10. MEHTA PHARMACEUTICAL INDUSTRIES CLARIFICATION COSMETIC DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. DESIGN, ADARSH NAGAR, DELHI APPROVAL 2. M/S. ARCHIES LIMITED, NEW DELHI APPROVAL 3. M/S. SHISEIDO INDIA PVT. LTD, MUMBAI APPROVAL 4. M/S. WIPRO ENTERPRISES LIMITED, BANGALORE APPROVAL 5. M/S. GILLETTE INDIA LIMITED, MUMBAI APPROVAL 6. M/S. DIVINE CARE, CHENNAI DEFICIENCY SUBSEQUENT NEW DRUG S. NO. NAME OF THE FIRM REFERENCE NO. FTS NO. TYPE OF 1. M/SINTAS CT NOC PHARMACEUTICALS 2. M/S SUN PHARMA AMENDMENT 3. M/S TROIKAA PHARMA DEFICIENCY 4. M/S BAYER DEFICIENCY PHARMACEUTICALS 5. M/S ABOTT DEFICIENCY HEALTHCARE 6. M/S ALLERGAN INDIA DEFICIENCY 7. M/S ALCON LABORATORIES TEST LICENSE
3 BA/BE DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. 01 M/S. QPS BIOSERVE INDIA PVT., HYDERABAD 02 M/S. BIOANALYTICAL LABORATORY, GRAND CENTRE, PANACEA BIOTECH, MUMBAI STATUS APPROVAL QUERY 03 M/S. LAMBDA THERAPEUTIC RESEARCH, MUMBAI QUERY LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. SUN PHARMACEUTICALS, GUJARAT 02 M/S. SHREE KRISHNA KESHAV, GUJARAT APPROVAL APPROVAL VACCINE DIVISION S. NO. COMPANY NAME DY. NO. STATUS 1 M/S SERUM INSTITUTE OF INDIA 2 M/S RELIANCE LIFE SCIENCES PVT,,LTD (FTS NO) APPROVAL (FTS NO) APPROVAL 3 M/S CADILA HEALTHCARE LIMITED 32738, 32741, 33938, (FTS NO) APPROVAL 4 M/S NOVO MEDI SCIENCES CLARIFICATION
4 PVT, LTD 5 M/S INTERVET INDIA PVT, LTD 21431, 9003 CLARIFICATION 6 M/S FRONTIER LIFELINE CLARIFICATION 7 M/S REGENERATIVE MEDICAL SERVICES PVT. LTD 8 M/S INTAS PHARMACEUTICALS 9 M/S NOVO NORDISK INDIA PVT, LTD CLARIFICATION CLARIFICATION APPROVAL 10 M/S GLOBION INDIA PVT, LTD CLARIFICATION 11 M/S WOCKHARDT LTD CLARIFICATION 12 M/S BIOLOGICAL E. LTD (FTS NO) APPROVAL 13 M/S L.V. PRASAD EYE INSTITUTE 14 M/S BHARAT SERUM AND VACCINE LTD APPROVAL CLARIFICATION MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ARTHOPLASTY APPROVAL (F-IL) 2. M/S. BARD INDIA HEALTHCARE PVT APPROVAL (F-RC) 3. M/S. BARD INDIA HEALTHCARE PVT APPROVAL (F-IL) 4. M/S. BECTON DICKINSON INDIA PVT APPROVAL (F-RC) 5. M/S. BECTON DICKINSON INDIA PVT APPROVAL (F-IL) 6. M/S. BIOMET ORTHOPAEDIC INDIA PVT APPROVAL (E-IL) 7. M/S. BOSTON SCIENTIFIC INDIA PVT APPROVAL (F-RC)
5 8. M/S. BOSTON SCIENTIFIC INDIA PVT APPROVAL (F-IL) 9. M/S. BOSTON SCIENTIFIC INDIA PVT M/S. CARDIO MEDICAL DEVICES PVT APPROVAL (F-IL) 11. M/S. CARL ZEISS INDIA (BANGALORE ) PVT. 12. M/S. CARL ZEISS INDIA (BANGALORE ) PVT APPROVAL (E-RC) 9926 APPROVAL (E-IL) 13. M/S. CLINICARE (INDIA) PVT APPROVAL (F-IL) 14. M/S. COOK INDIA MEDICAL DEVICES PVT APPROVAL (CT) 15. M/S. DEEP MEDICAL DEVICES PVT APPROVAL (F-IL) 16. M/S. EURO MEDI TOOLS PVT APPROVAL (F-IL) 17. M/S. GLOBAL SURGICALS PVT APPROVAL (F-IL) 18. M/S. HESTER DIAGNOSTIC PVT APPROVAL (F-IL) 19. M/S. INNVOLUTION HEALTHCARE PVT APPROVAL (F-IL) 20. M/S. INNVOLUTION HEALTHCARE PVT APPROVAL (F-IL) 21. M/S. INDIA MEDTRONIC PVT APPROVAL (R-RC) 22. M/S. INDIA MEDTRONIC PVT APPROVAL (R-IL) 23. M/S. JOHNSON & JOHNSON PVT M/S. KOX MED & LAB PVT APPROVAL (F-IL) 25. M/S. LIFELONG MEDITECH M/S. MERIT MEDICAL SYSTEMS INDIA PVT APPROVAL (F-IL) 27. M/S. NOBEL BIOCARE INDIA PVT APPROVAL (TL) 28. M/S. NOBEL BIOCARE INDIA PVT APPROVAL (TL) 29. M/S. NOBEL BIOCARE INDIA PVT APPROVAL (TL) 30. M/S. PAREKH INTEGRATED SERVICES PVT APPROVAL (F-IL)
6 31. M/S. SHAH DISTRIBUTORS APPROVAL (R-IL) 32. M/S. SHUBHAN ENTERPRISES APPROVAL (F-IL) 33. M/S. SPINEMED SYSTEMS PVT APPROVAL (R-IL) 34. M/S. TOTIPOTENT SC SCIENTIFIC PRODUCTS PVT. 35. M/S. VASCULAR THERAPEUTICS INDIA PVT APPROVAL (E-IL) APPROVAL (F-IL) 36. M/S. WEALTH TAXI TECHNOLOGY PVT CLARIFICATION 37. M/S. BECTON DICKINSON INDIA PVT QUERY 38. M/S. AMARANTE WELLNESS ZONE CLARIFICATION 39. M/S. HEALTHY OPTION PVT CLARIFICATION 40. M/S. STERICATGUTSRINGS PVT M/S. B BRAUN MEDICAL (INDIA0 PVT QUERY 42. M/S. TROIKAA PHARMACEUTICAL M/S. JOHNSON & JOHNSON PVT M/S. JOHNSON & JOHNSON PVT THE JOINT COMMISSIONER (KD), THANE (CLAA) QUERY DDC, CDSCO, MUMBAI (CLAA) M/S. GEORGE PHILIPS MEDICAL ENGINEERING PVT. 46. THE COMMISSIONER, GANDHINAGAR (CLAA) DDC, CDSCO, AHMEDABAD (GUJ.) (CLAA) APPROVAL M/S. BIOTECH VISION CARE PVT. 47. THE COMMISSIONER, GANDHINAGAR (CLAA) DDC, CDSCO, AHMEDABAD (GUJ.) (CLAA) APPROVAL
7 M/S. SAHAJANAND MEDICAL TECHNOLOGIES PVT. 48. M/S. S3V VASCULAR TECHNOLOGIES PVT. 49. M/S. S3V VASCULAR TECHNOLOGIES PVT APPROVAL (F-RC) 4778 APPROVAL (F-IL) DIAGNOSTICS DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. AIMS APPROVAL (IL) 2. M/S. ALERE MEDICAL PVT APPROVAL (E-IL) 3. M/S. ALLIED BIOTECHNOLOGY INDIA PVT APPROVAL (IL) 4. M/S. ARKRAY HEALTHCARE PVT APPROVAL (IL) 5. M/S. BECKMAN COULTER INDIA PVT APPROVAL (IL) 6. M/S. BECKMAN COULTER INDIA PVT APPROVAL (IL) 7. M/S. BECKMAN COULTER INDIA PVT M/S. BIOMERIEUX INDIA PVT M/S. BIOMERIEUX INDIA PVT APPROVAL (IL) 10. M/S. BIO-RAD LABORATORIES (INDIA) PVT APPROVAL (IL) 11. M/S. DHR HOLDING INDIA PVT APPROVAL (IL) 12. M/S. EURO DIAGNOSTIC SYSTEMS PVT APPROVAL (E-IL) 13. M/S. HALYARD HEALTH INDIA PVT APPROVAL (IL)
8 14. M/S. IMMUCOR INDIA PVT APPROVAL (IL) 15. M/S. JOHNSON & JOHNSON PVT M/S. KRYPTON BIOMEDICAL PVT APPROVAL (IL) 17. M/S. LILAC MEDICARE PVT APPROVAL (IL) 18. M/S. LILAC MEDICARE PVT M/S. LILAC MEDICARE PVT M/S. LILAC MEDICARE PVT APPROVAL (E-IL) 21. M/S. LILAC MEDICARE PVT APPROVAL (E-IL) 22. M/S. PAMMVI EXPORTS PVT APPROVAL (IL) 23. M/S. PINKI SCIENTIFIC APPROVAL (IL) 24. M/S. ROCHE DIAGNOSTICS INDIA PVT APPROVAL (E-IL) 25. M/S. ROCHE DIAGNOSTICS INDIA PVT APPROVAL (E-IL) 26. M/S. SANDOR MEDICAIDSPVT APPROVAL (IL) 27. M/S. SIEMENS LIMITED APPROVAL (IL) 28. M/S. SIEMENS LIMITED APPROVAL (IL) 29. M/S. SIEMENS LIMITED APPROVAL (IL) 30. M/S. SIEMENS LIMITED APPROVAL (E-IL) 31. M/S. SIEMENS LIMITED APPROVAL (IL) 32. M/S. SIEMENS LIMITED APPROVAL (E-IL) 33. M/S. SYSMEX INDIA PVT APPROVAL (IL) 34. M/S. TRANSASIA BIO-MEDICALS LIMITED APPROVAL (IL) 35. M/S. TRANSASIA BIO-MEDICALS LIMITED APPROVAL (IL) 36. M/S. TRANSASIA BIO MEDICALS LIMITED APPROVAL (E-IL) 37. M/S. TRIVITRON HEALTHCARE PVT APPROVAL (IL) 38. M/S. TRIVITRON HEALTHCARE PVT APPROVAL (IL) 39. M/S. UNIQUE DIAGNOSTICS & SCIENTIFIC APPROVAL (IL)
9 40. M/S. WERFEN MEDICAL INDIA PVT APPROVAL (IL) 41. M/S. ATHENESEDX PVT BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI M/S. ALEMBIC PHARMACEUTICALS, VADODARA M/S. APOTEX RESEARCH PVT., BANGALORE M/S. AZIDUS LABORATORIES, CHENNAI M/S. CADILA HEALTHCARE,, AHMEDABAD AMENDMENT TEST LICENCE AMENDMENT TEST LICENCE TEST LICENCE TEST LICENCE 7. M/S. CIPLA LIMITED, MUMBAI APPROVAL 8. M/S. CIPLA LIMITED, MUMBAI TEST LICENCE 9. M/S. CIPLA LIMITED, MUMBAI TEST LICENCE 10. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD M/S. HIGLANCE LABORATORIES PVT., GREATER NOIDA , U.P. 12. M/S. LOTUS LABS PVT., BANGALORE M/S. LUPIN LIMITED (RESEARCH PARK), PUNE AMENDMENT APPROVAL TEST LICENCE AMENDMENT
10 14. M/S. MANIPAL ACUNOVA, MANGALORE M/S. QUEST LIFE SCIENCES (P), CHENNAI M/S. SEMLER RESEARCH CENTER, BANGALORE M/S. SYNGENE INTERNATIONAL, BANGALORE M/S. WATSON PHARMA PVT., NAVI MUMBAI M/S. WATSON PHARMA PVT., NAVI MUMBAI M/S. WATSON PHARMA PVT., NAVI MUMBAI APPROVAL APPROVAL AMENDMENT CLARIFICATION APPROVAL APPROVAL APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
LETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709
LETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
LETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
LETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
LETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
LETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)
LETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
TODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
Recent trends and challenges
INTERNATIONAL CONFERENCE ON Recent trends and challenges in Bioanalysis Tentative Program Bioanalytica-2017 Hyderabad,India JUNE 30, 2017 Invitation ABC Biologics welcomes you to attend the international
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
1 Agio Pharmaceuticals Limited 15/31/2013-EP(Engg) dt:21.11.2013 7,98,217.00 2 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt:21.11.2013 15,10,268.00 3 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg)
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
Subsequent New Drugs Division. M/s.Troikaa. M/s. Olive Healthcare. Biological Division. M/s. Wockhardt Ltd. Global Clinical Trial Division
: The34 th SEC (Endocrinology & Metabolism) meeting held on 25.04.2017 at CDSCO HQ New Delhi and recommended the following: Age Subsequent New Drugs Division 1 12-146/2016-DC (Pt- Zim-Snd) Vitamin D3 (Cholecalciferol)
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF SPTEMBER-2013 DATE OF HEARING 10.09.2013 R. T. M. 1. 842945/16 Rect. AMD-249059 Mr. Pankajbhai Sitaram Nayak, Hearing on Section
Education. Current Activities
Nirali Mehta, M.Sc., M.Phil. Founder & Consultant Biostatistician Ahmedabad, Gujarat, India. M +91 9377060504 E nirali.mehta@pharma-stats.in W www.pharma-stats.in Education 1998-2001 Bachelor of Science
3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.
MINUTES OF THE 6 th MEETING OF TECHNICAL COMMITTEE HELD ON 25-07-2013 UNDER CHAIRMANSHIP OF DGHS FOR SUPERVISING CLINICAL TRIALS ON NEW CHEMICAL ENTITIES IN THE LIGHT OF DIRECTIONS OF THE HON BLE SUPREME
Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33
Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF JUNE-2016 DATE OF HEARING 13.06.2016 1. 934855/05 Opp. AMD-245342 M/s. Ajanta Pharma Limited, Mumbai / Mr. Manoj G. Menda, Mumbai
AGENDA PAPERS FOR THE EIGHTEENTH MEETING SUB-COMMITTEE ON LARGE ANIMALS (SCLA)
AGENDA PAPERS FOR THE EIGHTEENTH MEETING OF SUB-COMMITTEE ON LARGE ANIMALS (SCLA) DATE : 18.04.2005 TIME : 3 : 00 P.M. VENUE : 8 TH FLOOR, JEEVAN PRAKASH BUILDING, 25, KASTURBA GANDHI MARG, NEW DELHI.
10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE
10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS
GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS HLC029D January 2013 Paul Evers Project Analyst ISBN: 0-89336-238-7 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 02 Sep 2018 23:38:24 GMT) CTRI Number Last Modified On 05/02/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast
Companies Database, Mobile Database, Id Database, Credit
m All India Database We Provides Database Companies Database, Mobile Database, Email Id Database, Credit Card Holder Database, Corporate database, CEO s Database, Corporate Employee Database, Car s Owner
Ameya works predominantly in the architectural design, interiors and project management segments in healthcare industry
Introduction Ameya design is premier health care consultancy firm with experience with design and execution of largest number of private sector health care facility in India. Key Information Ameya works
Aina Blood Monitoring System
Aina Blood Monitoring System Analytical Performance Summary The Aina Blood Monitoring System is a high quality and versatile multi-parameter diagnostic platform that is CE-marked and approved for sale
Solvay in India January, 2014
Solvay in India January, 2014 SOLVAY in India, Innovation and Operational excellence Jodhpur Hichem (JV) Ahmedabad Hichem (JV) Bhiwani Hichem (JV) Delhi Hichem (JV) Solvay R&D center Vadodara Panoli Solvay
Exporting Heart Disease to Developing Countries: India. Zeeshan Ali, Ph.D.
Exporting Heart Disease to Developing Countries: India Zeeshan Ali, Ph.D. Mortality Rate Heart disease is the number one cause of mortality. Accounts for one-fourth of all deaths in India. Source: Gupta
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 11 Jan 2019 05:36:45 GMT) CTRI Number Last Modified On 30/03/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
CAREER AIM POSTGRADUATE TRAINING & EXPERIENCE
Dr. Abhishek Parmar DNB. ( CTVS ), MS, MBBS. Consultant. HCG Hospital. AHMEDABAD CAREER AIM I enjoy the enormous responsibility that caring for a critically ill Cardiac and Thoracic patient entails and
Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division
Recommetions of thesec (Dermatology & Allergy) made in its 23 rd meeting held on 11.05.2017 at CDSCO HQ New Delhi: File /Drug Name Recommetions New Drugs Division 1 12-28/15-DC (Pt-B) Apremilast 10/20/30
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
Disbursement of MDA Claims to Individual Exporters during (-11) 1 JPN Pharma API China 80,000.00 2 Unique Biotech Limited Bio May 3-6, 80,000.00 3 Titan Biotech Limited Cphi Japan 21st to 23rd April 80,000.00
INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2
G B Pant Hospital J L Nehru Marg, Delhi Cardiac Anaesthesia 1 Delhi-110002 Indraprastha s Delhi Cardiac Anaesthesia 1 Medanta- The Medicity Sector-38, Gurgaon, Haryana Cardiac Anaesthesia 5 Haryana-122001
ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
CANCER INSTITUTE (WIA) CANAL BANK ROAD, ADYAR, CHENNAI
Minutes of Pre-bid Conference CANCER INSTITUTE (WIA) Procurement of : Digital Mammography Unit BIDREFERENCE : CI: SCI: BB/RAD/P-I/2016-17/02 DATED 15/12/2016 Venue : Board Room, Lion Cancer Support Center,
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
REF/2014/04/ CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 02 May 2018 19:38:55 GMT) CTRI Number Last Modified On 13/12/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on 05.11.2014 and recommended the following:- Agend a No. File No. 1. File No.: 12-75/13-DC Afatinib film coated tablet
Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023
Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,
New Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs
Central Drugs Standard Control Organization Directorate General of Health Services Ministry of Health and Family Welfare Government of India New Drugs Division Frequently Asked Questions (FAQs) on Approval
Central Inspection Plan Using Risk Based Approach Of Vaccine Manufacturing Units for 2017
, follow-up, failure A NORTH ZONE 1 M/s Biomed Pvt. Ltd, C-96, Site I, Bulandshahar Road, Ind. Area, Ghaziabad. 1. Oral Polio Vaccine IP, 2. Vi Typhoid Vaccine (Bio Typh TM ) IP, 3. Haemophilus Type-B
Hyderabad, India Delegates. April 27, Tentative program A comprehensive Bioanalysis conclave. Key notes.
INTERNATIONAL CONFERENCE &EXHIBITION Tentative program A comprehensive Bioanalysis conclave 7+ Key notes 50+ Poster presentations 100+ Delegates 2 + Panel Discussions April 27, 2018 Hyderabad, India Invitation
CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 07 Oct 2018 22:54:26 GMT) CTRI Number Last Modified On 11/05/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
New: Li st of TPAs List of TPA's released by IRDA Updated C on Oct lick Here.
TPA List In India // Third Party Administrators for Health Insurance are a link between the insured A Third Party Administrator is the same as an ASO - administrative services only company. The duties
TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016 RECOMBINANT PRODUCTS S. No. Firm Name of Formulation Import License No. &
Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products
Market ation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Bichemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, and Commercial Labs Partial Table of
Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research
Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research " Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market
WHO list of prequalified in vitro diagnostic products
WHO list of in vitro diagnostic products : Rest of the world. Regulatory version applied to products not approved by stringent/mature NRAs or not regulated Last update: 8 April 2016 Year 2016 HIV RDT OraQuick
Mud/double Pot Hole/ Natural Draft / chimney. Model: 2-Pot hole raised type Mud ICS. Safety. Mud/double Pot Hole/ Natural Draft / chimney
Lists of Nepal Interim Benchmark for solid biomass Cook stoves (NIBC, 2016) approved biomass cook stoves (Tested by RETS according to single sample provided) 1. ICS1109 () Designer: Alternative Energy
SEAT MATRIX - FELLOWSHIP PROGRAMMES - CENTRALIZED COUNSELING ADMISSION SESSION. Andhra Pradesh. Andhra Pradesh. Andhra Pradesh.
1 3 4 5 6 7 Care Apollo Yashoda Super Fernandez Pvt. Ltd. Global s Ltd., Apollo, Road No. 1, Banjara Hills, Hyderabad - 34 Jubilee Hills, Hyderabad-34 Raj Bhavan Road, Somajiguda, Hyderabad-8 4-1-130,
Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products
Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Bichemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS HLC046C November 2014 Mary C. Patton Project Analyst ISBN: 1-56965-982-6 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 24 Nov 2018 11:16:02 GMT) CTRI Number CTRI/2010/091/000422 [Registered on: 05/08/2010] - Last Modified On 01/03/2013 Post Graduate Thesis Type of Trial
RENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
RENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS BIO138A January 2015 Cheng-Yuk Lee Project Analyst ISBN: 1-62296-003-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 024 USA 866-285-7215 (toll-free
SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Reference Code: GDME0220RDB Publication Date: January 2013
Decisions taken in the 63 rd Meeting of the Genetic Engineering Approval Committee (GEAC) held on 8 th February 2006.
Decisions taken in the 63 rd Meeting of the Genetic Engineering Approval Committee (GEAC) held on 8 th February 2006. The 63 rd Meeting of the Genetic Engineering Approval Committee was held on 8 th February
List of Ordinary Members as on NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT
Sl No NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT MICROCELL INDUSTRIES 5 ADLIFE HEALTHCARE PVT. LTD. 6 AKUMS DRUGS & PHARMACEUTICALS LTD 7 ALCON
SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
Global Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
Directorate General of Health Services Office of Drugs Controller General (India) (Biological Division)
Directorate General of Health Services Office of Drugs Controller General (India) (Biological Division) List of r-dna drug products approved in the country (Form 45 and 45A) from 1 st Jan 2015 to 30 th
Vaccine Technologies and Global Markets
A BCC Research Pharmaceutical Report and Global Markets PHM014D Use this report to: Learn about the strengths and weaknesses of each category of human and veterinary vaccine to prevent or treat infectious
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 7 Immunology 2017 MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 29 Sep 2018 17:14:38 GMT) CTRI Number CTRI/2008/091/000087 [Registered on: 19/06/2008] - Last Modified On 05/08/2013 Post Graduate Thesis Type of Trial
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 09 Mar 2019 16:29:06 GMT) CTRI Number CTRI/2010/091/000679 [Registered on: 23/08/2010] - Last Modified On 10/07/2015 Post Graduate Thesis Type of Trial
INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes January, 2018
Agenda: Friday, 19th January 2018 07:30-17:00. INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes 19-20 January, 2018 Hotel J.
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 19 Apr 2019 13:49:20 GMT) CTRI Number CTRI/2009/091/000126 [Registered on: 15/04/2009] - Last Modified On 03/09/2014 Post Graduate Thesis Type of Trial
Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
Case 3:15-cv-05982-PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 Liza M. Walsh Christine I. Gannon CONNELL FOLEY LLP One Newark Center 1085 Raymond Boulevard, 19th Floor Newark, New Jersey
Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee
College of American Pathologists (CAP) GH5 Survey Data: (updated 12/17) The American Diabetes Association (ADA) recommends that The A1C test should be performed using a method that is certified by the
Tamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.
Number of Companies consisting of Market Share of 1% & Above 2 3.1 Adrenaline Injection 1 mg/ml Per ml Sum of MAT value considered for price calculation (in Lakhs) 152.69 Sum of PTR per unit considered
WHO list of prequalified in vitro diagnostic products
WHO list of in vitro diagnostic products : Rest of the world. Regulatory version applied to products not approved by stringent/mature NRAs or not regulated Last update: 21 December 2016 Year 2016 HIV RDT
Nitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam
Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,
WHO list of prequalified in vitro diagnostic products
WHO list of prequalified in vitro diagnostic products : Rest of the world. Regulatory version applied to products not approved by stringent/mature NRAs or not regulated Last update: 17 March 2017 Year
DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)
DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p
Lists of Nepal Interim Benchmark for solid biomass Cook stoves (NIBC, 2016) approved biomass cook stoves (Tested by RETS)
Lists of Nepal Interim Benchmark for solid biomass Cook stoves (NIBC, 2016) approved biomass cook stoves (Tested by RETS) 1. ICS1109 () Designer: Alternative Energy Promotion Center (AEPC) Khumaltar Height,
Blood Glucose Test Strip Market Research Report- Global Forecast till 2020
Report Information More information from: https://www.marketresearchfuture.com/reports/976 Blood Glucose Test Strip Market Research Report- Global Forecast till 2020 Report / Search Code: MRFR/MED/0470-CRR
Global Vitamin Market Professional Survey Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Vitamin Market Professional Survey Report 2016 Global Vitamin Market Professional Survey Report 2016 Publication
WHITE PAPER 3D PRINTED SURGICAL GUIDES AND MEDICAL INSTRUMENTS
WHITE PAPER ON 3D PRINTED SURGICAL GUIDES AND MEDICAL INSTRUMENTS BRIEF INTRODUCTION Surgical guides are used to increase accuracy, safety and predictability while operating on a patient. The 3D Printed
1. Dr. Shyam Agarwal, Joint Secretary, Department of Commerce. 2. Shri A.K. Bamba, Director, Department of Commerce
Minutes of Meeting of Inter Ministerial Committee (IMC) for consideration of proposals for setting up ICDs / CFSs held under Chairmanship of Shri P.K. Chaudhery, Additional Secretary (AS), Department of
100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010
Currently Approved CBER Device Premarket Applications (PMAs) As of Nov 10, 2014 Sorted by Applicant Name BP090080-0 BP060002-0 BP120037-0 BP090022-0 BP090032-0 BP040046-0 BP100064-0 BP140120-0 Abbott Laboratories
Excipient Regulations Perspective & Creation of IPEC India (Current Regulations & Emerging challenges for excipient regulations in India)
INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL OF INDIA (IPEC INDIA) Excipient Regulations Perspective & Creation of IPEC India (Current Regulations & Emerging challenges for excipient regulations in
### About Bharat Biotech
Press Release Bharat Biotech Bharat Biotech Launches Typbar-TCV, world s first clinically proven typhoid conjugate vaccine for infants 6 months & older and Adults The new vaccine brings hope to millions
Regulatory Reforms-Future of Plasma Protein Therapy in India
Regulatory Reforms-Future of Plasma Protein Therapy in India Ranjeet S. Ajmani PlasmaGen BioSciences Pvt. Ltd. Bangalore, India PPB-2013 Price Tag of Contrast q Uniqueness q Co-existence : Rich & Poor